Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jan 26;10(1):e0117704.
doi: 10.1371/journal.pone.0117704. eCollection 2015.

The role of IL-23/Th17 pathway in patients with primary immune thrombocytopenia

Affiliations

The role of IL-23/Th17 pathway in patients with primary immune thrombocytopenia

Xin Ye et al. PLoS One. .

Abstract

Background: Primary immune thrombocytopenia (ITP) is an autoimmune bleeding disorder with an unclear etiology. This study aims to investigate the role of IL-23/Th17 pathway in patients with ITP.

Method: The gene expressions of IL-17, IL-23 and their receptors in ITP patients and healthy controls were analyzed by quantitative real-time PCR. ELISA was used to test the IL-17 and IL-23 levels in plasma. Flow cytometry was used to detect the frequency of Th17 cells. The correlation between plasma IL-23 and IL-17 levels, Th17 cells, platelets were analyzed. The level of Th17-related cytokines was measured by ELISA following stimulation with IL-23. Subsequently, the IL-23 and IL-17 levels were measured in patients post-treatment.

Results: The PBMCs of ITP patients showed increased mRNA expression levels in each of the following: IL-23p19, IL-12p40, IL-23R, IL-12Rβ1, IL-17A, IL-17F, and RORC. In addition, elevated Th17 cells and plasma IL-17, IL-23 levels were also observed in these ITP patients. Furthermore, it was found that IL-23 levels in plasma are positively correlated with IL-17 levels and Th17 cells, yet negatively correlated with platelet count. Following IL-23 stimulation in vitro, IL-17 levels showed significant elevation. Furthermore, both IL-23 and IL-17 levels decreased after effective treatment.

Conclusion: The IL-23/Th17 pathway may be involved in the pathogenesis of ITP through enhancement of the Th17 response. Moreover, our results suggest that the IL-23/Th17 pathway is a potential therapeutic target in future attempts of ITP treatment.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. IL-23/Th17 pathway related molecules mRNA relative expression.
*P<0.01.
Fig 2
Fig 2. Plasma IL-23 and IL-17 levels in ITP patients and healthy controls.
*P<0.01.
Fig 3
Fig 3. Percentage of Th17 cells in ITP patients and healthy controls.
Fig 4
Fig 4. Correlation between plasma IL-23 and IL-17, Th17, platelets in ITP patients.
Fig 5
Fig 5. Th17 related cytokines production in culture supernatant in the presence and absence of IL-23.
Fig 6
Fig 6. Plasma IL-23 and IL-17 level change in ITP patients after effective treatment.

Similar articles

Cited by

References

    1. McKenzie CG, Guo L, Freedman J, Semple JW (2013) Cellular immune dysfunction in immune thrombocytopenia (ITP). Br J Haematol 163: 10–23. 10.1111/bjh.12480 - DOI - PubMed
    1. Semple JW, Provan D, Garvey MB, Freedman J (2010) Recent progress in understanding the pathogenesis of immune thrombocytopenia. Curr Opin Hematol 17: 590–595. 10.1097/MOH.0b013e32833eaef3 - DOI - PubMed
    1. Coopamah MD, Garvey MB, Freedman J, Semple JW (2003) Cellular immune mechanisms in autoimmune thrombocytopenic purpura: An update. Transfus Med Rev 17: 69–80. - PubMed
    1. Cooper N, Bussel J (2006) The pathogenesis of immune thrombocytopaenic purpura. Br J Haematol 133: 364–374. - PubMed
    1. Semple JW, Provan D (2012) The immunopathogenesis of immune thrombocytopenia: T cells still take center-stage. Curr Opin Hematol 19: 357–362. 10.1097/MOH.0b013e3283567541 - DOI - PubMed

Publication types

MeSH terms